While the opposing paradigms of RET function may present challenges in the treatment of RET-altered CRC tumors, further analyses are required to determine whether tumor-suppressive or oncogenic RET occurs in specific subpopulations of CRC tumors. The gene discussed is RET; the disease is neoplasm.